Podcast Episode

Chapters

Rumor vs Truth - Evidence‑Based Mythbusting for Healthcare Professionals

Generic Meds

Sep 15, 2026 Season 2 Episode 9 TRC Healthcare

Generic drugs save money, but do they lower the bar?

From what "bioequivalent" really requires to why an authorized generic can look just like the brand name, a lot of what gets assumed about generic drugs hasn't caught up with how tightly this corner of pharmacy is actually regulated.

In this episode, Don and Steve pick apart the claims pharmacists hear most about generic drugs.

🔬 Do generics really get held to a lower approval or quality bar than the brand drug?
📦 Is an authorized generic just the brand drug repackaged in a different box?
🔄 Is it safe to switch between generics from different manufacturers?
📛 Are generic drug names really just made up?

We'll check the label on the evidence and find out which generic claims are the real deal:

Generics have lower approval and quality standards.
Authorized generics are the same product as the brand drug.
Switching between generics is safe.
Generic drug names are just made up.

🏷️ Use code rvt1026 at checkout for 10% off a new or upgraded subscription.

******

TRC Healthcare Editor Hosts:

Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC
Don Weinberger, PharmD, PMSP

******

Guest:

Doug Hoey, RPh, MBA (Chief Executive Officer of the National Community Pharmacists Association, NCPA)

******

CE Information:

None of the speakers have anything to disclose.

TRC Healthcare offers CE credit for this podcast for subscribers at our platinum level or higher. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

Claim Credit

******

The clinical resources related to this podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: